Answers are grounded in this paper and cite their sources.
Background : This study is done to determine the occurrence of Candidemia among the neonatal patients during 3 years of observation alongwith to analyze the trend in species distribution and to examine in vitro susceptibility to common antifungal drugs. Materials and Methods :A retrospective review of 2312 blood samples collected from the neonates admitted in Neonatal Intensive Care Unit and Sick Newborn Care Unit in 2019, 2020, 2021 and 2022 were done.Neo-nates who had a positive blood culture for fungal element, were enrolled.Incidence of albicans and non-albicans candidemia were evaluated.Drug sensitivity test was employed to determine the sensitivity of Voriconazole, Itraconazole, Fluconazole and Amphotericin B. Results :Out of blood samples collected from 2312 neonates with suspected Blood stream infection, 568 (24.6%) samples were detected with blood stream infection.Among which 89 samples were identified as fungal isolates and out of those samples candidemia afflicted 83 samples.Among the positive isolates predominant isolate was Candida albicans 47.0% (39/83) followed by Candida tropicalis 26.5% (22/83), Candida glabrata 13.3% (11/83), Candida parapsilosis 7.2% (6/83) and Candida guillermondii 6.0% (5/83).Majority of candidemia were due to Non-albicans Candida ie, 53.0% of total positive cases.Among the Low Birth Weight (LBW) babies majority were due to C albicans.Susceptibility testing revealed that 92.8% of the retrieved Candida isolates were sensitive to voriconazole, 48.2% to Fluconazole while only 31.3% to Itraconazole and 26.5% to Amphotericin B Albicans candida showed comparatively higher resistance to Fluconazole (58.8% against 45.4%) & Itraconazole (71.8% against 65.9%); whereas Non-albicans Candida showed comparatively higher resistance to Voriconazole (9.1% against 5.1%) and Amphotericin B (88.6% against 56.4%). Conclusion :Candida spp are assuming an increasing role in nosocomial infections in neonates.The World-wide progressive shift towards Non-albicans Candidemia and increasing resistant pattern to many regularly used antifungals necessitates regular surveillance and monitoring of laboratory data.
No takes yet. Share an insight, caveat, or question.
Pal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: